Novel CLL therapies: the future

Novel CLL therapies: the future

VJHemOnc

1 year
151 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
The multitude of novel therapies in the field of chronic lymphocytic leukemia (CLL) paves the way for exciting future possibilities. In this interview, Jennifer Woyach, MD, of the Ohio State University Comprehensive Cancer Center, Columbus, OH, discusses some of these possibilities at the British Society for Haematology (BSH) 2018 Annual Meeting, held in Liverpool, UK. Explored is the use of novel therapies earlier in the treatment pathway and in combination, with the goal of discontinuing therapy in the future, avoiding the toxicity and excessive cost of taking agents for extended periods of time. Moreover, Dr Woyach touches upon a variety of exciting trials: the Phase III ALLIANCE A041202 trial comparing the efficacy of bendamustine and rituximab vs. ibrutinib and rituximab in high-risk elderly CLL (NCT01886872); the ECOG-E1912 Phase III trial comparing a combination of ibrutinib and rituximab vs. fludarabine, cyclophosphamide and rituximab in younger patients (NCT02048813); and a German CLL Study Group trial exploring the effect of early intervention with rituximab for high-risk patients.
Up Next Autoplay
Phase 3 DUO Study @ospniguarda
Phase 3 DUO Study @ospniguarda
Category: Chronic Lymphocytic Leukemia
9 Views
Cancer-News 1 week
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
ASH 2016 Page 3 Maintenance Therapy in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
201 Views
cancergrace 5 months
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
ASH 2016 Page 2 Update on New Chronic Lymphocytic Leukemia Drugs
Category: Chronic Lymphocytic Leukemia
92 Views
cancergrace 5 months
CLL, What is the significance of IGHV mutations and how are they assessed
CLL, What is the significance of IGHV mutations and how are they assessed
Category: Chronic Lymphocytic Leukemia
87 Views
cancergrace 5 months
Not Your Fathers CLL with Dr. John Pagel
Not Your Fathers CLL with Dr. John Pagel
Category: Chronic Lymphocytic Leukemia
114 Views
cancergrace 5 months
CLL, Is there a role still for chemo AND who should get chemo
CLL, Is there a role still for chemo AND who should get chemo
Category: Chronic Lymphocytic Leukemia
75 Views
cancergrace 5 months
CLL, FCR vs BR – Is One Better
CLL, FCR vs BR – Is One Better
Category: Chronic Lymphocytic Leukemia
178 Views
cancergrace 5 months
The Role of CAR-T Therapy in B-Cell Lymphomas
The Role of CAR-T Therapy in B-Cell Lymphomas
Category: Chronic Lymphocytic Leukemia
69 Views
obr 5 months
Outcomes from RESONATE Trial in Relapsed CLL
Outcomes from RESONATE Trial in Relapsed CLL
Category: Chronic Lymphocytic Leukemia
68 Views
obr 5 months
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
CLL-14 Data Trial in Chronic Lymphocytic Leukemia
Category: Chronic Lymphocytic Leukemia
149 Views
obr 5 months